Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Total Bangun Persada Tbk. (TOTL) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Total Bangun Persada Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Total Bangun Persada Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Total Bangun Persada Tbk. trades at Rp1,055 (market cap 3.56T, 919.7K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 3.3× Total Bangun Persada Tbk.'s market cap, and Total Bangun Persada Tbk. is more actively traded (919.7K versus 429.7K). Which is the better fit depends on your goals.

TOTLTSPC
Market Cap
3.56T11.68T
Volume
919.7K429.7K
Lot
9.2K4.3K
Turnover
966.06M1.11B
Average Price
1,050.412,591.65
Value
966.06M1.11B
Indicative Equilibrium Price
1,0552,580
Indicative Equilibrium Volume
294100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

TOTL
View details
TSPC
View details

About Total Bangun Persada Tbk.

PT Total Bangun Persada (the company) was established under its original name of PT Tjahja Rimba Kentjana on Sep 4, 1970 then changed to PT Total Bangun Persada based on Notaries Deed dated Jul 24, 1981 and the deed of establishment was approved by the the Ministry of Justice dated Nov 4, 1981. The Company’s articles of association has been amended several times, most recently by notarial deed No. 47 of Haryanto, S.H., dated Oct 24, 2005, concerning the amendment of Company's authorized and paid up capital, and public offering.

Read more on TOTL

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC